A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors. En savoir plus sur A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumors.
Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma. En savoir plus sur Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.